CD80+ and CD86+B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

RT @johanvawe: In #neuroinflammation , @SorayaMariaMen1 also showed ex vivo treatment with IFN-β but not IFN-α resulted in higher B cell CD…

In #neuroinflammation , @SorayaMariaMen1 also showed ex vivo treatment with IFN-β but not IFN-α resulted in higher B cell CD86 expression in healthy controls, patients with HAM/TSP and #MultipleSclerosis , similar to in vivo treatment in MS. https://t.co/E

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 myelopathy and multiple sclerosis http://t.co/AZ5DrdtOmh

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 myelopathy and multiple sclerosis http://t.co/AZ5DrdtOmh